Femtech company Mira is collaborating with ŌURA, allowing users of the Finnish company’s Oura smart ring to access lab-grade hormone testing data.
The integration allows Mira users to view everyday wellness data, such as sleep, readiness, and temperature trends, from ŌURA directly alongside their hormone data in Mira’s app. The companies hope the alliance will reveal how hormonal changes influence how women feel, sleep, and function day to day.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
According to Mira, hormones affect nearly every system in the body yet are rarely measured or contextualised with daily health signals. The San Francisco-based company asserted that by bringing these data streams together in one app, Mira and ŌURA can help women “move beyond isolated metrics” to understand relational patterns between their hormonal and other healthcare metrics provided by Oura smart ring.
Mira recently conducted a survey of 2,000 women, finding that 77% believed regular tracking through wearables and health monitors – such as hormones, sleep, or stress – could help prevent future health issues.
Mira CEO Sylvia Kang highlighted that while more women than ever are tracking their health metrics nowadays, they are rarely availed of the tools to see the real reasons behind their symptoms.
“With this integration, we’re connecting hormone data with daily health signals, giving women insights they can act on,” Kang said.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData“Understanding these patterns can change how women manage fertility, navigate perimenopause, or address hormonal imbalances,” she concluded.
According to a 2023 report from GlobalData, the wearable technology market is forecast to grow from $99.5bn in 2022 to $290.6bn in 2030.
Mira’s integration with ŌURA to give users further insight into healthcare metrics reflects a similar move Dexcom. In November 2024, the diabetes giant partnered with the smart ring developer to give users of its continuous glucose monitoring (CGM) system insight into how healthcare metrics such as poor sleep affect glucose variability and what meals cause glucose spikes.
The net result of these integrations is that users can identify relational patterns between these data to optimise and take better care with regard to their respective needs.
The partnership was established via a Dexcom investment of $75m into ŌURA. Currently, no other CGM is compatible with the Oura smart ring.
In a recent interview with Medical Device Network, David Benshoof Klein, CEO of digital therapeutics company Click Therapeutics, said the days of wearables collecting data and merely providing these insights back to users are numbered, with the inclusion of actionable insights set to become a critical differentiator in their future value proposition.
